Variant report
Variant | esv32890 |
---|---|
Chromosome Location | chr11:36343052-36343837 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-COMMD9-1 | chr11:36342708-36343153 | ENSG00000254566 |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs575138949 | chr11:36343073-36343074 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs542297632 | chr11:36343109-36343110 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs115528561 | chr11:36343123-36343124 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs547291012 | chr11:36343130-36343131 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs567191608 | chr11:36343150-36343151 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs535494217 | chr11:36343152-36343153 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs548946197 | chr11:36343162-36343163 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs569301937 | chr11:36343168-36343169 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs142109615 | chr11:36343191-36343192 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs571904426 | chr11:36343192-36343193 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs150907392 | chr11:36343203-36343204 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs534362576 | chr11:36343263-36343264 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs554520312 | chr11:36343301-36343302 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs372907589 | chr11:36343303-36343304 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs574372500 | chr11:36343308-36343309 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs372545606 | chr11:36343343-36343344 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs542671706 | chr11:36343349-36343350 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs34687494 | chr11:36343388-36343389 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs10742369 | chr11:36343390-36343391 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs558702451 | chr11:36343410-36343411 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs150193181 | chr11:36343411-36343412 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs139408939 | chr11:36343426-36343427 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs149889021 | chr11:36343430-36343431 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs369777704 | chr11:36343474-36343475 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs191558319 | chr11:36343482-36343483 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs540236195 | chr11:36343485-36343486 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs564778537 | chr11:36343515-36343516 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs183893858 | chr11:36343516-36343517 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs559755435 | chr11:36343535-36343536 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs370031632 | chr11:36343541-36343542 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs11603116 | chr11:36343608-36343609 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs189298623 | chr11:36343639-36343640 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs547247457 | chr11:36343648-36343649 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs529936295 | chr11:36343684-36343685 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs7127214 | chr11:36343693-36343694 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs192676831 | chr11:36343717-36343718 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs531561625 | chr11:36343766-36343767 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs570219951 | chr11:36343820-36343821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Medulloblastoma | 16783165 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Potocki-Shaffer syndrome | 19222835 | CNVD |
WAGR syndrome | 19222835 | CNVD |
Chordoma | 18071362 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 21364760 | CNVD |
Aniridia syndrome | 21572526 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Denys-drash syndrome | 21085971 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
WAGR syndrome | 16773131 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Aniridia syndrome | 17204608 | CNVD |
Mental retardation | 17204608 | CNVD |
WAGR syndrome | 19617690 | CNVD |
genitourinary abnormalities | 17204608 | CNVD |
Breast cancer | 16397240 | CNVD |
Mental retardation | 16773131 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Cancer | 17160897 | CNVD |
Cancer | 21183584 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
WAGR syndrome | 22470819 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Denys-drash syndrome | 19566914 | CNVD |
Familial wilms tumor | 19566914 | CNVD |
Frasier syndrome | 19566914 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
WAGR syndrome | 20603712 | CNVD |
Autism | 17322880 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Breast cancer | 21858162 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 16620391 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:36336800-36343400 | Weak transcription | Fetal Intestine Small | intestine |
2 | chr11:36341200-36346400 | Weak transcription | Brain Inferior Temporal Lobe | brain |
3 | chr11:36341200-36348400 | Weak transcription | H1 Cell Line | embryonic stem cell |
4 | chr11:36341400-36355800 | Weak transcription | Brain Substantia Nigra | brain |
5 | chr11:36342200-36348200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
6 | chr11:36342600-36343400 | Enhancers | Brain Cingulate Gyrus | brain |
7 | chr11:36342800-36343400 | Enhancers | Fetal Thymus | thymus |
8 | chr11:36342800-36343800 | Enhancers | Primary T helper memory cells from peripheral blood 1 | blood |
9 | chr11:36343000-36343200 | Enhancers | Brain Hippocampus Middle | brain |
10 | chr11:36343400-36343600 | Enhancers | Fetal Intestine Small | intestine |
11 | chr11:36343400-36344400 | Weak transcription | Fetal Thymus | thymus |
12 | chr11:36343800-36345800 | Weak transcription | Primary T helper memory cells from peripheral blood 1 | blood |